Found: 17
Select item for more details and to access through your institution.
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01688-w
- By:
- Publication type:
- Article
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01521-w
- By:
- Publication type:
- Article
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 1, p. 125, doi. 10.1111/head.14036
- By:
- Publication type:
- Article
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
- Published in:
- Neuroepidemiology, 2015, v. 44, n. 1, p. 16, doi. 10.1159/000369621
- By:
- Publication type:
- Article
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 339, doi. 10.1007/s40120-023-00575-5
- By:
- Publication type:
- Article
Cerebral lactate production and blood flow in acute stroke.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16131
- By:
- Publication type:
- Article
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1089, doi. 10.1111/ene.15670
- By:
- Publication type:
- Article
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217318822148
- By:
- Publication type:
- Article
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 2, p. 380, doi. 10.1111/bcp.12968
- By:
- Publication type:
- Article
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 5, p. 1, doi. 10.1177/03331024231170807
- By:
- Publication type:
- Article
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
- By:
- Publication type:
- Article
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
- By:
- Publication type:
- Article
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice